Portal de Periódicos da CAPES

Tetracycline Derivative CMT‐3 Inhibits Cytokine Production, Degranulation, and Proliferation in Cultured Mouse and Human Mast Cells

1999; Wiley; Volume: 878; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1999.tb07763.x

1749-6632

Kari K. Eklund, Timo Sorsa,

Click Chemistry and Applications

Annals of the New York Academy of SciencesVolume 878, Issue 1 p. 689-691 Tetracycline Derivative CMT-3 Inhibits Cytokine Production, Degranulation, and Proliferation in Cultured Mouse and Human Mast Cells KARI K. EKLUND, Corresponding Author KARI K. EKLUND Institute of Biomedicine, Department of Medical Chemistry and Department of Internal Medicine, Helsinki University Hospital, Helsinki, FinlandAddress for correspondence: Kari Eklund, Institute of Biomedicine, Department of Medical Chemistry, University of Helsinki, Siltavuorenpenger 10,00170 Helsinki, Finland.Search for more papers by this authorTIMO SORSA, TIMO SORSA Department of Dentistry, Helsinki University, Helsinki, FinlandSearch for more papers by this author KARI K. EKLUND, Corresponding Author KARI K. EKLUND Institute of Biomedicine, Department of Medical Chemistry and Department of Internal Medicine, Helsinki University Hospital, Helsinki, FinlandAddress for correspondence: Kari Eklund, Institute of Biomedicine, Department of Medical Chemistry, University of Helsinki, Siltavuorenpenger 10,00170 Helsinki, Finland.Search for more papers by this authorTIMO SORSA, TIMO SORSA Department of Dentistry, Helsinki University, Helsinki, FinlandSearch for more papers by this author First published: 06 February 2006 https://doi.org/10.1111/j.1749-6632.1999.tb07763.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Arnason, J. & D.G. Malone. 1995. Role of mast cells in arthritis. Chem. Immunol. 62: 204–238. 2 Kloppenburg, M., F.C. Breedveld, J.P. Terwiel, C. Mallee & B.A.C. Dijkmans. 1994. Minocycline in active rheumatoid arthritis: a double-blind placebo-controlled trial. Arthritis Rheum. 37: 629–636. 3 Tilley, B.C., G.S. Alarcon, S.P. Heyse, D.E. Trentham et al. 1995. Minocycline in rheumatoid arthritis: a 48-week, double blind, placebo controlled trial. Ann. Intern. Med. 122: 81–89. 4 Butterfield, J.H., D. Weiler, G. Dewald & G.J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 2: 345. Citing Literature Volume878, Issue1INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONSJune 1999Pages 689-691 ReferencesRelatedInformation